CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus

Lancet. 2018 Mar 24;391(10126):1126-1127. doi: 10.1016/S0140-6736(18)30544-0. Epub 2018 Mar 15.

Authors

David R Fernandez¹, Mary K Crow²

Affiliations

¹ Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY 10021, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
² Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY 10021, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: [email protected].

PMID: 29551336
DOI: 10.1016/S0140-6736(18)30544-0

No abstract available

Publication types

Comment

MeSH terms

CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes*
Humans
Lupus Erythematosus, Systemic*
TOR Serine-Threonine Kinases

Substances

MTOR protein, human
TOR Serine-Threonine Kinases